|
ZFYVE20 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14249720795101E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.60619999997913E-06 |
| Normal-vs-Stage2 |
2.62449995069858E-09 |
| Normal-vs-Stage3 |
2.66453525910038E-15 |
| Normal-vs-Stage4 |
2.44582132324922E-12 |
| Stage1-vs-Stage2 |
6.243200E-03 |
| Stage1-vs-Stage3 |
1.89530000027638E-07 |
| Stage1-vs-Stage4 |
3.87780000000726E-05 |
| Stage2-vs-Stage3 |
4.529600E-01 |
| Stage2-vs-Stage4 |
4.414800E-01 |
| Stage3-vs-Stage4 |
8.971600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.34470254112784E-12 |
| Normal-vs-AfricanAmerican |
2.993400E-04 |
| Normal-vs-Asian |
2.599400E-01 |
| Caucasian-vs-AfricanAmerican |
4.750400E-01 |
| Caucasian-vs-Asian |
1.869570E-01 |
| AfricanAmerican-vs-Asian |
4.042800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.13975537078204E-12 |
| Normal-vs-Female |
7.88819998209789E-09 |
| Male-vs-Female |
2.337200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.986390E-04 |
| Normal-vs-Age(41-60Yrs) |
8.42960001801174E-09 |
| Normal-vs-Age(61-80Yrs) |
5.30686605770825E-12 |
| Normal-vs-Age(81-100Yrs) |
7.20110000518304E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.617400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.943000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.019000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.160990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.721700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.030200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.271400E-01 |
| Normal-vs-Grade 2 |
1.53070999999727E-05 |
| Normal-vs-Grade 3 |
1.63080660087189E-12 |
| Normal-vs-Grade 4 |
1.63125069008174E-12 |
| Grade 1-vs-Grade 2 |
1.533960E-02 |
| Grade 1-vs-Grade 3 |
1.74139999997713E-06 |
| Grade 1-vs-Grade 4 |
3.10380000034804E-07 |
| Grade 2-vs-Grade 3 |
1.69405000000067E-05 |
| Grade 2-vs-Grade 4 |
2.5574999995559E-07 |
| Grade 3-vs-Grade 4 |
4.088000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.68856999999134E-05 |
| Normal-vs-ccB subtype |
4.42860192961803E-11 |
| ccA subtype-vs-ccB subtype |
4.155100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.10750364013779E-11 |
| Normal-vs-N1 |
8.16729999963961E-07 |
| N0-vs-N1 |
1.086360E-01 |
|
|
